Tag Archives: VICL

Top 10 Medical Stocks To Own Right Now

Yesterday, our Under the Radar Moversnewsletter suggested small cap Viveve Medical Inc (NASDAQ: VIVE) as a short/bearish trade:

This downtrend just firmed up with the “second wind” effort evidenced in just the past couple of trading days. After finding support for the better part of September and October, the floor finally broker in late October. A bounce started to take shape in early November, but all it took was a bump into the 20-day moving average line to put the pullback back into motion. Today’s and yesterday’s bar we’ve seen opens and closes at the lower end of the trading range, and so far today we’ve seen a lower low and lower high on very strong selling volume. Let’s just take the hint at face value.

Our Under the Radar Moversnewsletter has a more detailed discussion about Viveve Medicals technical chart along with a potential short/bearish trading strategy:

Top 10 Medical Stocks To Own Right Now: KongZhong Corporation(KZ)

Advisors’ Opinion:

  • [By Monica Gerson]

    The list of below stocks is notable as the shares have traded on sequentially increasing volume spanning the trading days from September 16 to September 20:

Top 10 Medical Stocks To Own Right Now: Best Buy Co., Inc.(BBY)

Advisors’ Opinion:

  • [By WWW.THESTREET.COM]

    Then there was Best Buy (BBY) with a surprisingly strong quarter.

    Many of the losers can be found at the mall, with Gap Stores (GPS) and Abercrombie & Fitch (ANF) continuing to disappoint. The only winner at the mall was Childrens’ Place (PLCE) , but Cramer said he’s not counting out a turnaround at L Brands (LB) .

  • [By Peter Graham]

    The Q3 2017 earnings report for large cap consumer electronics retail stock Best Buy Co Inc (NYSE: BBY) is scheduled before the market opens onThursday (November 17th) as a technical chart shows shares still in an apparent uptrend albeit also appearing to have leveled off or be range bound since mid-August:

  • [By Ben Levisohn]

    The folks at Bespoke Investment Group note that its “Death By Amazon” index, which includesBest Buy (BBY), Barnes & Noble (BKS), Wal-Mart Stores (WMT), and Macy’s (M), among other traditional retailers that have been hurt by Amazon.com’s (AMZN) dominance, has been outperforming since Donald Trump’s election victory:

Top 10 Medical Stocks To Own Right Now: BlackRock, Inc.(BLK)

Advisors’ Opinion:

  • [By Shauna O’Brien]

    UBS announced on Wednesday that it has cut its rating on investment management firm BlackRock, Inc. (BLK).

    The firm has downgraded BlackRock from “Buy” to “Neutral” due to expenses, which are putting pressure on margins. UBS also lowered its price target on BLK to $280, which suggests a 5% upside from the stock’s current price of $266.51.

    BlackRock shares were down $2.51, or 0.94%, during pre-market trading Wednesday. The stock is up 29% YTD.

  • [By Tom Aspray, Senior Editor, MoneyShow.com]

    Some of the emerging market ETFs are already up 7%, so far, this month, as it seems like others are drawing the same conclusions. Robert Kapito, co-founder of BackRock, Inc. (BLK), which has assets of $3.9 trillion, said that “The emerging markets are going to account for about 60 to 65% of the world’s growth over the next 20 years.”

Top 10 Medical Stocks To Own Right Now: Vical Incorporated(VICL)

Advisors’ Opinion:

  • [By Lisa Levin]

    Vical Incorporated (NASDAQ: VICL) shares dropped 22 percent to $3.01 after the company disclosed that its Phase 2 trial did not meet primary endpoint.

Top 10 Medical Stocks To Own Right Now: Brown(n)

Advisors’ Opinion:

  • [By Alex Jordon]

    He already owns a good chunk of NetSuite (N), whose revenue grew 35% last quarter, beating earnings estimates by $0.03 a share. Ellison’s been profiting from the cloud while dismissing its significance. With the Salesforce agreement his company is, too. (Fool)

  • [By Arie Goren]

    On November 5, Oracle (NYSE:ORCL)confirmed that it has finally completed the acquisition of Netsuite (NYSE:N) for $9.3 billion in cash, or $109 per share that the company had initially offered. In my previous article about Oracle, I had suggested that the acquisition of NetSuite, the cloud business application software company, is a smart move by Oracle. What’s more, it is not paying an excessive price for the deal. In fact, Oracle insisted that it will not pay more than what it had first offered despite the resistance from T Rowe Price (NSDQ:TROW)which demanded $133 per share.

Top 10 Medical Stocks To Own Right Now: Rite Aid Corporation(RAD)

Advisors’ Opinion:

  • [By Matthew Smith]

    Speaking of subsectors in the retailing industry we are bullish on, how about the drugstores? They all seem to be running on all cylinders and yesterday Rite-Aid (RAD) had a tremendous day. It was the heaviest traded stock on all of the exchanges and saw its shares rise $0.87 (23.45%) to close at $4.58/share. Rite-Aid is the first among the ‘Big Three’ to report quarterly results so we find it interesting that they saw an increase in same store sales and saw profits driven by generic drugs. We have been told that this is going to be the bottom line driver for the industry via nearly everyone and that it would impact the top line as generics replaced the more expensive branded drugs. We care about earnings growth more than revenue growth, especially when the stall in revenues is due to switching to higher margin product which is purchased for a lower price. The market gets this and is pushing all of these names higher. In hindsight we wish we had been more bullish of Rite-A id earlier, but hindsight is always perfect.

  • [By Benzinga News Desk]

    Shares of Rite Aid (NYSE: RAD) surged to a high of $7.89 following a DealReporter story that Walgreens (NASDAQ: WBA) is close to reaching a deal to satisfy the US FTC, which would involve divestiture of up to 1,000 stores. Companies interested in the Walgreen's assets are said to include Kroger, Albertsons, CVS Health, Kinney Drugs and Fred's.

  • [By Teresa Rivas]

    Rite Aid (RAD) was up more than 15% at recent check, near six-year highs, as its second quarter surprised investors with an unexpected profit.

    The drugstore said it earned $32.8 million, or three cents a share, compared with a year-earlier loss of $38.8 million, or a nickel a share. Analysts were looking for a per-share loss of four cents for the period ended August 31.

    Rite Aids total sales climbed 0.8% to $$6.28 billion, while same-store sales rose 1%, as a 0.3% decline in front-end sales was more than offset by a 1.7% increase in pharmacy sales.

    In addition, Rite Aid also increased its forecast, saying it now expects to earn to between 18 cents and 27 cents a share on sales of $25.1 billion to $25.3 billion and same-store sales of plus or minus 0.5%. The companys EPS estimate is above expectations, while the revenue guidance is in-line with current forecasts.

    At recent check, rival Walgreen (WAG), the nations largest chain, was up 0.5%, while CVS Caremark (CVS), the second-largest drugstore operator, was down 0.1%.

  • [By Ben Levisohn]

    Chase announced that the company will process payments for Wal-Mart on the companys closed-loop network, ChaseNet. We would expect the economics of the deal to benefit Wal-Mart and thus the signing of the agreement and onboarding of another payment processor. The real takeaway for us is that today’s announcement adds one of the largest US retailers by revenues to the growing list of merchants that already accept ChaseNet including: Starbucks (SBUX), Marriott (MAR), United (UAL), Rite Aid (RAD), and Chevron (CVX). Thus, JPMorgan is building scale on the company’s platform and that needs to continue longer term.

  • [By Monica Gerson]

    Analysts expect Rite Aid Corporation (NYSE: RAD) to report its quarterly earnings at $0.06 per share on revenue of $8.40 billion. Rite Aid shares gained 0.25 percent to $8.15 in after-hours trading.

Top 10 Medical Stocks To Own Right Now: Citrix Systems Inc.(CTXS)

Advisors’ Opinion:

  • [By Monica Gerson]

    Benzinga's newsdesk monitors options activity to notice unusual patterns. These large volume (and often out of the money) trades were initially published intraday in Benzinga Professional . These trades were placed during Thursday’s regular session.

Top 10 Medical Stocks To Own Right Now: Liberty Global plc(LBTYA)

Advisors’ Opinion:

  • [By Alex Webb]

    Kabel Deutschland is a key part of Vodafones expansion strategy as the carrier looks for ways to boost revenue and lock in customers with Internet and television offers in addition to wireless service. Kabel Deutschland is the biggest cable company in Germany, Vodafones largest market, and had drawn a rival bid from John Malones Liberty Global Plc. (LBTYA)

Top 10 Medical Stocks To Own Right Now: Silver Bay Realty Trust Corp.(SBY)

Advisors’ Opinion:

  • [By Mark Holder]

    Instead of competing in one-off auctions, the traditional method of acquiring homes and the one preferred by Silver Bay Realty Trust (NYSE: SBY  ) (NYSE: SBY  ) (NYSE: SBY  ) and American Homes 4 Rent (NYSE: AMH  ) (NYSE: AMH  ) (NYSE: AMH  ) , the company is obtaining non-performing loans in pools that include thousands of loans. The ultimate outcome of these different models is unknown, but the market hasso far supported Altisource Residential.

Top 10 Medical Stocks To Own Right Now: Potash Corporation of Saskatchewan Inc.(POT)

Advisors’ Opinion:

  • [By Daniela Pylypczak]

    Morgan Stanley announced on Monday that it has resumed coverage on Potash Corp (POT).

    Morgan Stanley analyst Vincent Andrews stated that the company has assigned the fertilizer stock an “Equal Weight” rating, warning “We remain cautious on the overall potash market, though more because of loose supply/demand fundamentals than because of dynamics in Russia/Belorussia. Potash prices have been moving lower for 8 quarters in a row now (7 of which BPC was fully functioning) and prices were continuing to drift lower in the weeks preceding the BPC break-up (recall Mosaic’s disclosure about lower prices in the Brazilian market on its July 16th earnings call.”

    Potash shares popped 1.55% during Monday’s session. Year-to-date, the stock has fallen 21.35%.

  • [By Cameron Swinehart]

    A diversified agriculture ETF with holdings in a variety of the largest agribusiness companies globally. Holdings include Bunge (BG), Archer Daniel Midland (AMD), PotashCorp (POT) and Deere (DE).

  • [By Jon C. Ogg]

    Potash Corp. of Saskatchewan Inc. (NYSE: POT) was up 25 at $33.12 in Monday afternoon trading. Monday’s gain puts shares up within striking distance of its breakout point from the aftermath this summer that took shares from $38 to $31 and ultimately back under $30 before recovering.

  • [By Chad Fraser]

    The agriculture ETF is heavily weighted toward the U.S., with 45.8% of its assets there, but it is geographically diverse, with exposure to countries such as Canada (9.9%), Switzerland (8.5%), Japan (6.7%) and Singapore (5.1%).

    Potash Cartel Breakup Has Weighed on This Agriculture ETF

    The ETF’s unit price declined in the first half of 2013, partly because of the breakup of the Belarusian Potash Company (BPC), through which Russia’s Uralkali, the world’s No. 1 potash producer, and Belaruskali of Belarus distribute their potash. The market is dominated by BPC and Canpotex, owned by Potash Corp. of Saskatchewan (NYSE: POT), Mosaic and Agrium Inc. (NYSE: AGU).

    Together, the two cartels control 70% of global potash exports, so the breakup of BPC will result in a more fractured market, which seems likely to push potash prices lower. Shares of major potash producers fell sharply on the news, as did Market Vectors Agribusiness ETF due to its potash stock holdings, which include Agrium, Potash Corp. and Mosaic.

5 Stocks Under $10 Set to Soar

DELAFIELD, Wis. (Stockpickr) — There isn’t a day that goes by on Wall Street when certain stocks trading for under $10 a share don’t experience massive spikes higher. Traders savvy enough to follow the low-priced names and trade them with discipline and sound risk management are banking ridiculous coin on a regular basis.

>>5 Rocket Stocks to Buy for Summer Gains

Just take a look at some of the big movers in the under-$10 complex from Thursday, including USEC (USU), which soared higher by 22%; NeoGenomics (NEO), which ripped to the upside by 20%; Timberline Resources (TLR), which spiked higher by 13.8%; and Timmins Gold (TGD), which trended to the upside by 12.7%. You don’t even have to catch the entire move in lower-priced stocks such as these to make outsized returns when trading.

One low-priced wireless communications player that recently ripped to the upside was NII Holdings (NIHD), which I highlighted in July 11’s “5 Stocks Under $10 Set to Soar” at around 64 cents per share. I mentioned in that piece that shares of NII Holdings recently formed a double bottom chart pattern at around 57 to 54 cents per share. This stock was just starting to flirt with its 50-day moving average of 63 cents per share and it was quickly moving within range of triggering a major breakout trade above a key downtrend line at around 66 cents per share.

>>5 Stocks With Big Insider Buying

Guess what happened? Shares of NII Holdings started to trigger that breakout the same day as I highlighted the stock in my piece with decent upside volume. Then the following trading session shares of NIHD ripped sharply to the upside with strong upside volume, after 12.39 million shares traded vs. its three-month average action of 5.03 million shares. Shares of NIHD tagged an intraday high on July 15 of 84 cents per share, which represents a monster of gain of 30% in just three trading sessions. As you can see, trading small-cap stocks that breakout with volume can produce large profits very quickly.

Low-priced stocks are something that I tweet about on a regular basis. I frequently flag high-probability setups, breakout candidates and low-priced stocks that are acting technically bullish. I like to hunt for low-priced stocks that are showing bullish price and volume trends, since that increases the probability of those stocks heading higher. These setups often produce monster moves higher in very short time frames.

>>5 Big Stocks to Trade for Gains This Summer

When I trade under-$10 names, I do it almost entirely based off of the charts and technical analysis. I also like to find under-$10 names with a catalyst, but that’s secondary to the chart and volume patterns.

With that in mind, here’s a look at several under-$10 stocks that look poised to potentially trade higher from current levels.

Aviat Networks

One under-$10 technology player that’s starting to trend within range of triggering a major breakout trade is Aviat Networks (AVNW), which designs, manufactures and sells a range of wireless networking products, solutions, and services in North America and Internationally. This stock has been hit hard by the sellers so far in 2014, with shares off sharply by 45%.

>>3 Big Tech Stocks on Traders’ Radars

If you take a glance at the chart for Aviat Networks, you’ll see that this stock has been uptrending over the last two months and change, with shares moving higher from its low of 99 cents per share to its recent high of $1.35 a share. During that uptrend, shares of PRKR have been consistently making higher lows and higher highs, which is bullish technical price action. That move has now pushed shares of AVNW within range of triggering a major breakout trade.

Traders should now look for long-biased trades in AVNW if it manages to break out above some near-term overhead resistance levels at $1.28 to $1.30 a share and then once it clears $1.35 a share with high volume. Look for a sustained move or close above those levels with volume that hits near or above its three-month average action of 861,975 shares. If that breakout triggers soon, then AVNW will set up to re-fill some of its previous gap-down-day zone from May that started near $1.60 a share.

Traders can look to buy AVNW off weakness to anticipate that breakout and simply use a stop that sits just below its 50-day moving average of $1.15 a share. One can also buy AVNW off strength once it starts to clear those breakout levels with volume and then simply use a stop that sits a comfortable percentage from your entry point.

Vical

An under-$10 biotechnology player that’s starting to trend within range of triggering a big breakout trade is Vical (VICL), which is engaged in the research and development of biopharmaceutical products based on its DNA delivery technologies for the prevention and treatment of serious or life-threatening diseases. This stock has been trending lower over the last three months, with shares off by 24%.

>>4 Big Stocks Everyone Is Talking About

If you take a look at the chart for Vical, you’ll notice that this stock has recently formed a double bottom chart pattern at $1.12 to $1.14 a share. Following that bottom, shares of VICL have started to trend back above its 50-day moving average of $1.20 with strong upside volume flows. This move has now pushed shares of VICL within range of triggering a big breakout trade above some key near-term overhead resistance levels.

Market players should now look for long-biased trades is VICL if it manages to break out above its 200-day moving average of $1.27 to some more key overhead resistance at $1.30 with high volume. Look for a sustained move or close above those levels with volume that hits near or above its three-month average action of 955,230 shares. If that breakout gets started soon, then VICL will set up to re-test or possibly take out its next major overhead resistance levels at $1.36 to $1.40, or even $1.50 to $1.60 a share.

Traders can look to buy VICL off weakness to anticipate that breakout and simply use a stop that sits right below its 50-day at $1.20 or below more key near-term support at $1.14 a share. One can also buy VICL off strength once it starts to clear those breakout levels with volume and then simply use a stop that sits a comfortable percentage from your entry point.

Ascent Solar Technologies

One under-$10 solar power player that’s starting to trend within range of triggering a major breakout trade is Ascent Solar Technologies (ASTI), which designs and manufactures photovoltaic integrated consumer electronics as well as portable power applications for commercial and military users. This stock has been hammered lower by the bears so far in 2014, with shares down sharply by 40%.

>>3 Stocks Rising on Unusual Volume

If you take a glance at the chart for Ascent Solar Technologies, you’ll notice that this stock recently formed a double bottom chart pattern at 38 cents to 39 cents per share. Shares of ASTI are now starting to spike sharply higher off those support levels and back above its 50-day moving average of 41 cents per share. Volume on Thursday registered 1.29 million shares, which is well above three-three month average action of 747,366 a share. That move is quickly pushing shares of ASTI within range of triggering a major breakout trade above some key near-term overhead resistance levels.

Traders should now look for long-biased trades in ASTI if it manages to break out above some near-term overhead resistance levels at 45 to 48 cents per share and then once it clears 50 cents per share with high volume. Look for a sustained move or close above that level with volume that hits near or above its three-month average action of 747,366 shares. If that breakout materializes soon, then ASTI will set up to re-test or possibly take out its next major overhead resistance levels at 55 to 60 cents per share, or even its 200-day moving average of 65 cents per share.

Traders can look to buy ASTI off weakness to anticipate that breakout and simply use a stop that sits right below some key near-term support levels at 39 to 38 cents per share or near 37 to 36 cents per share. One can also buy ASTI off strength once it starts to bust above those breakout levels with volume and then simply use a stop that sits a comfortable percentage from your entry point.

xG Technology

An under-$10 wireless communications player that’s starting to move within range of triggering a near-term breakout trade is xG Technology (XGTI), which develops communications technologies for wireless networks worldwide. It primarily offers a portfolio of intellectual property to enhance wireless communications. This stock is off to a hot start in 2014, with shares up sharply by 35%.

>>Beat the S&P With 5 Stocks Everyone Else Hates

If you look at the chart for xG Technology, you’ll see that this stock has been consistently making higher lows for the last two months and change. This higher lows chart pattern has now formed a strong support level for shares of XGTI each time it has pulled back over that timeframe. Shares of XGTI counter-trended higher on Thursday vs. the overall market weakness and the stock flirted with and closed above its 200-day moving average. That move is quickly pushing shares of XGTI within range of triggering a near-term breakout trade above some key overhead resistance levels.

Market players should now look for long-biased trades in XGTI if it manages to break out above Thursday’s intraday high of $2.22 a share to some more key overhead resistance at $2.35 a share with high volume. Look for a sustained move or close above those levels with volume that registers near or above its three-month average volume of 1.02 million shares. If that breakout gets underway soon, then XGTI will set up to re-test or possibly take out its next major overhead resistance levels at $3.01 to $3.85 a share.

Traders can look to buy XGTI off weakness to anticipate that breakout and simply use a stop that sits right below some near-term support at $2 a share or right around its 50-day moving average of $1.85 a share. One can also buy XGTI off strength once it starts to move above those breakout levels with volume and then simply use a stop that sits a comfortable percentage from your entry point.

Highpower International

One final under-$10 stock that looks ready to trigger a near-term breakout trade is Highpower International (HPJ), which manufactures and trades nickel metal hydride rechargeable batteries for portable electronic devices. This stock is off to a blazing hot start in 2014, with shares up substantially by 80%.

If you take a glance at the chart for Highpower International, you’ll see that this stock has recently formed a major bottoming chart pattern over the last month and change, with shares finding buying support at $4.13, $4.40 and $4.20 a share. Shares of HPJ counter-trend higher versus the overall market weakness on Thursday as the stock bounced notably higher right off its 50-day moving average of $4.37 a share. That spike is starting to push shares of HPJ within range of triggering a near-term breakout trade above some key overhead resistance levels.

Traders should now look for long-biased trades in HPJ if it manages to break out above some near-term overhead resistance levels at $4.78 to $5 a share and then once it takes out more key overhead resistance levels at $5.28 to $5.33 a share with high volume. Look for a sustained move or close above those levels with volume that registers near or above its three-month average volume of 260,744 shares. If that breakout kicks off soon, then HPJ will set up re-test or possibly take out its next major overhead resistance levels at $5.68 to $6.50, or even around $7 to $7.50 a share.

Traders can look to buy HPJ off weakness to anticipate that breakout and simply use a stop that sits right around some key near-term support levels at $4.20 to $4.13 share. One can also buy HPJ off strength once it starts to clear those breakout levels with volume and then simply use a stop that sits a comfortable percentage from your entry point.

To see more hot under-$10 equities, check out the Stocks Under $10 Setting Up to Explode portfolio on Stockpickr.

— Written by Roberto Pedone in Delafield, Wis.

RELATED LINKS:

>>5 Breakout Stocks for a Market Near All-Time Highs

>>3 Big-Volume Stocks in Breakout Territory

>>5 Stocks Set to Soar on Bullish Earnings

Follow Stockpickr on Twitter and become a fan on Facebook.

At the time of publication, author had no positions in stocks mentioned.

Roberto Pedone, based out of Delafield, Wis., is an independent trader who focuses on technical analysis for small- and large-cap stocks, options, futures, commodities and currencies. Roberto studied international business at the Milwaukee School of Engineering, and he spent a year overseas studying business in Lubeck, Germany. His work has appeared on financial outlets including

CNBC.com and Forbes.com. You can follow Pedone on Twitter at www.twitter.com/zerosum24 or @zerosum24.

5 Stocks With Big Insider Buying

DELAFIELD, Wis. (Stockpickr) — Corporate insiders sell their own companies’ stock for a number of reasons.

>>Should You Invest in the Government’s 5 Favorite Stocks?

They might need the cash for a big personal purchase such as a new house or yacht, or they might need the cash to fund a charity. Sometimes they sell as part of a planned selling program that they have put in place for diversification purposes, which allows them to sell stock in stages instead of selling all at one price.

Other times they sell because they think their stock is overvalued and the risk/reward is no longer attractive. Some even dump their own stock because they have inside knowledge that a competitor is eating their lunch and stealing market share.

But insiders usually buy their own shares for one reason: They think the stock is a bargain and has tremendous upside.

>>5 Hated Earnings Stocks You Should Love

The key word in that last statement is “think.” Just because a corporate insider thinks his or her stock is going to trade higher, that doesn’t mean it will play out that way. Insiders can have all the conviction in the world that their stock is a buy, but if the market doesn’t agree with them, the stock could end up going nowhere. Also, I say “usually” because sometimes insiders are loaned money by the company to buy their own stock. Those loans are often sweetheart deals and shouldn’t be viewed as organic insider buying.

At the end of the day, it’s large institutional money managers running big mutual funds and hedge funds that drive stock prices, not insiders. That said, many of these savvy stock operators will follow insider buying activity when they agree with the insider that the stock is undervalued and has upside potential. This is why it’s so important to always be monitoring insider activity, but it’s twice as important to make sure the trend of the stock coincides with the insider buying.

>>5 Rocket Stocks to Stomp the S&P in 2014

Recently, a number of companies’ corporate insiders have bought large amounts of stock. These insiders are finding some value in the market, which warrants a closer look at these stocks. Here’s a look five stocks whose insiders have been doing some big buying per SEC filings.

Seacoast Banking Corp. of Florida

One mid-Atlantic banking player that insiders are loading up on here is Seacoast Banking Corp. of Florida (SBCF), which provides community banking services to commercial, small business, and retail customers in Florida. Insiders are buying this stock into modest strength, since shares are up 9% during the last month.

Seacoast Banking Corp. of Florida has a market cap of $228 million and an enterprise value of $360 million. This stock trades at a premium valuation, with a trailing price-to-earnings of 4.95 and a forward price-to-earnings of 25.50. Its estimated growth rate the next quarter is 100%, and for next year it’s pegged at -81.2%. This is not a cash-rich company, since the total cash position on its balance sheet is $108.35 million and its total debt is $237.95 million.

>>The Case for a Correction in Stocks

A director just bought 2.3 million shares, or about $5 million worth of stock, at $2.15 per share.

From a technical perspective, SBCF is currently trending above both its 50-day and 200-day moving averages, which is bullish. This stock has been uptrending over the last three months and change, with shares moving higher from its low of $10.10 to its recent high of $12.49 a share. During that uptrend, shares of SBCF have been making mostly higher lows and higher highs, which is bullish technical price action. That move has now pushed shares of SBCF within range of triggering a near-term breakout trade.

If you’re bullish on SBCF, then I would look for long-biased trades as long as this stock is trending above its 50-day at $11.55 and then once breaks out above its 52-week high at $12.49 a share with high volume. Look for a sustained move or close above that level with volume that hits near or above its three-month average action of 86,640 shares. If that breakout hits soon, then SBCF will set up to enter new 52-week-high territory, which is bullish technical price action. Some possible upside targets off that breakout are $15 to $17 a share.

Dycom Industries

Another stock that insiders are active in here is Dycom Industries (DY), which provides specialty contracting services in the U.S. and Canada. Insiders are buying this stock into decent strength, since shares are up 12.7% during the last six months.

>>4 Stocks Breaking Out on Big Volume

Dycom Industries has a market cap of $956 million and an enterprise value of $1.41 billion. This stock trades at a reasonable valuation, with a trailing price-to-earnings of 22.91 and a forward price-to-earnings of 15.06. Its estimated growth rate for this year is 25.4%, and for next year it’s pegged at 27%. This is not a cash-rich company, since the total cash position on its balance sheet is $14.39 million and its total debt is $484.33 million.

A director just bought 15,000 shares, or about $419,000 worth of stock, at $27.99 per share.

From a technical perspective, DY is currently trending above both its 50-day and 200-day moving averages, which is bullish. This stock has been consolidating and trending sideways over the last month and change, with shares moving between $26.17 on the downside and $28.95 on the upside. Shares of DY are now starting to move within range of triggering a major breakout trade above the upper-end of its recent sideways trading chart pattern.

If you’re in the bull camp on DY, then I would look for long-biased trades as long as this stock is trending above some key near-term support levels at $26.96 or at $26.17 and then once it breaks out above some near-term overhead resistance levels at $28.40 to $28.95 a share with high volume. Look for a sustained move or close above those levels with volume that hits near or above its three-month average action of 182,684 shares. If that breakout triggers soon, then DY will set up to re-test or possibly take out its 52-week high at $31.75 a share. Any high-volume move above $31.75 will then give DY a chance to tag $34 to $35 a share.

Vical

One biopharmaceutical player that insiders are jumping into here is Vical (VICL), which engages in the research and development of biopharmaceutical products based on its DNA delivery technologies for the prevention and treatment of serious or life-threatening diseases. Insiders are buying this stock into big weakness, since shares are down by 53% over the last six months.

>>3 Biotech Stocks Under $10 to Watch

Vical has a market cap of $151 million and an enterprise value of $67.38 million. This stock trades at a premium valuation, with a price-to-sales of 20.02 and a price-to-book of 2.19. Its estimated growth rate for this year is -51.9%, and for next year it’s pegged at 22%. This is a cash-rich company, since the total cash position on its balance sheet is $55.85 million and its total debt is zero.

The CEO just bought 330,000 shares, or about $468,000 worth of stock, at $1.42 per share. Two vice presidents also just bought 180,000 shares, or about $254,000 worth of stock, at $1.42 per share.

From a technical perspective, VICL is currently trending above its 50-day moving average and below its 200-day moving average, which is neutral trendwise. This stock has uptrending strong over the last month and change, with shares soaring higher from its low of $1.01 to its intraday high of $1.79 a share. During that uptrend, shares of VICL have been consistently making higher lows and higher highs, which is bullish technical price action. Shares of VICL have just started to break out above some key overhead resistance levels at $1.53 to $1.64 a share. That breakout has sent the stock into a massive gap-down-day zone from last August that started around $3.50 a share.

If you’re bullish on VICL, then I would look for long-biased trades as long as this stock is trending above $1.53 or above $1.35 and then once it takes out Wednesday’s intraday high of $1.79 a share with high volume. Look for a sustained move or close above that level with volume that hits near or above its three-month average volume of 1.34 million shares. If we get that move soon, then VICL will set up to re-fill some more of its previous gap-down-day zone that started near $3.50 a share. Some possible upside targets are $2.50 to $3 a share.

Actuant

Another stock that insiders are jumping into here is Actuant (ATU), which designs, manufactures and distributes a range of industrial products and systems worldwide. Insiders are buying this stock into modest weakness, since shares are off by just 2% over the last three months.

>>5 Big Trades to Take This Year

Actuant has a market cap of $2.69 billion and an enterprise value of $3.02 billion. This stock trades at a reasonable valuation, with a trailing price-to-earnings of 92.22 and a forward price-to-earnings of 15.83. Its estimated growth rate for this year is 2%, and for next year it’s pegged at 14.8%. This is not a cash-rich company, since the total cash position on its balance sheet is $109.54 million and its total debt is $503 million.

A vice president just bought 7,000 shares, or about $251,000 worth of stock, at $35.93 per share.

From a technical perspective, ATU is currently trending above its 200-day moving average and just below its 50-day moving average, which is neutral trendwise. This stock has just started to rebound off its 200-day moving average at $35.51 a share. That move is quickly pushing shares of ATU within range of triggering a near-term breakout trade.

If you’re bullish on ATU, then I would look for long-biased trades as long as this stock is trending above its 200-day at $35.51 or above more support at $35.39 and then once it breaks out above some near-term overhead resistance levels at $37.04 to its 50-day moving average of $37.63 a share with high volume. Look for a sustained move or close above those levels with volume that hits near or above its three-month average volume of 530,665 shares. If that breakout hits soon, then ATU will set up to re-test or possibly take out its next major overhead resistance levels at $39 to its 52-week high at $39.84 a share. Any high-volume move above those levels will then give ATU a chance to trend well north of $40 a share.

Spark Networks

One final stock with some decent insider buying is Spark Networks (LOV), which provides online personals services in the U.S. and internationally. Insiders are buying this stock into major weakness, since shares are down by 29% during the last six months.

Spark Networks has a market cap of $145 million and an enterprise value of $131 million. This stock trades at a reasonable valuation, with a price-to-sales of 2.14 and a price-to-book of 8.07. Its estimated growth rate for this year is 25, and for next year it’s pegged at 48.1%. This is a cash-rich company, since the total cash position on its balance sheet is $17.24 million and its total debt is zero.

A beneficial owner just bought 98,638 shares, or about $616,000 worth of stock, at $6.23 per share.
From a technical perspective, LOV is currently trending below both its 50-day and 200-day moving averages, which is bearish. This stock has been trending sideways and consolidating for the last few weeks, with shares moving between $5.99 on the downside and $6.55 on the upside. So far, that $5.99 level has been tested a few times and has formed a double bottom chart pattern. If that level can hold, then shares of LOV could start to rebound and move within range of triggering a near-term breakout trade.

If you’re bullish on LOV, then look for long-biased trades as long as this stock is trending above support at $5.99 and then once it breaks out above its 50-day at $6.19 to some more near-term overhead resistance at $6.55 a share with high volume. Look for a sustained move or close above those levels with volume that hits near or above its three-month average action of 147,773 shares. If that breakout triggers soon, then LOV will set up to re-test or possibly take out its next major overhead resistance levels at $7.30 to its 200-day moving average of $7.42 a share. Any high-volume move above those levels will then give LOV a chance to tag $8 to $8.50 a share.

To see more stocks with notable insider buying, check out the Stocks With Big Insider Buying portfolio on Stockpickr.

— Written by Roberto Pedone in Delafield, Wis.


RELATED LINKS:



>>Invest Like a Venture Capitalist With These 5 Stocks



>>3 Tech Stocks Rising on Big Volume



>>5 Stocks Under $10 Set to Soar

Follow Stockpickr on Twitter and become a fan on Facebook.

At the time of publication, author had no positions in stocks mentioned.

Roberto Pedone, based out of Delafield, Wis., is an independent trader who focuses on technical analysis for small- and large-cap stocks, options, futures, commodities and currencies. Roberto studied international business at the Milwaukee School of Engineering, and he spent a year overseas studying business in Lubeck, Germany. His work has appeared on financial outlets including

CNBC.com and Forbes.com. You can follow Pedone on Twitter at www.twitter.com/zerosum24 or @zerosum24.